AFMD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Affimed (AFMD) Earnings Date & Reports

Affimed NV is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AFMD is expected to report earnings to fall 6.27% to -56 cents per share on May 21

Q1'25

Est.

$-0.57

Q4'24

Beat

by $0.11

Q3'24

Missed

by $0.09

Q2'24

Missed

by $0.04

Q1'24

Beat

by $0.28

The last earnings report on March 27 showed earnings per share of -60 cents, beating the estimate of -71 cents. With 4.46K shares outstanding, the current market capitalization sits at 12.11M.

View a ticker or compare two or three

Compare

AFMD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AFMD
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of antibody-based therapeutic drugs

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Gottlieb-Daimler-Strabe 2

Phone

+49 621560030

Employees

Web

https://www.affimed.com